Русский
English
عربي
Boehringer Ingelheim
Boehringer Ingelheim is a global pharmaceutical company founded in 1885 in Ingelheim, Germany. The company focuses on research and development of innovative medicines in the fields of human pharmaceuticals, animal health, and biopharmaceutical contract manufacturing.
Key Areas of Focus:
-
Human Pharmaceuticals:
- Boehringer Ingelheim develops drugs for diseases such as cardiovascular conditions, cancer, respiratory diseases, and diabetes.
- The company emphasizes treatments for conditions with high unmet medical needs, providing innovative and effective therapies.
-
Animal Health:
- Boehringer Ingelheim produces veterinary medicines, vaccines, and healthcare products for pets, livestock, and farm animals.
-
Biopharmaceutical Contract Manufacturing:
- The company offers contract manufacturing services for biopharmaceuticals, specializing in complex biologics for other pharmaceutical companies.
Research and Innovation:
- Boehringer Ingelheim invests heavily in research and development to discover new drugs and therapies, with a focus on areas such as oncology, immunology, respiratory diseases, and chronic conditions.
Notable Products:
- Pradaxa (dabigatran): An oral anticoagulant for preventing blood clots.
- Spiriva (tiotropium): A treatment for chronic obstructive pulmonary disease (COPD).
- Vibativ (telavancin): An antibiotic for complicated skin and soft tissue infections.
Global Presence:
- Boehringer Ingelheim employs more than 50,000 people worldwide and operates production facilities, research centers, and manufacturing sites in multiple countries.
Brand products
OUR PARTNERS
